69 related articles for article (PubMed ID: 1501857)
21. Subsequent malignancies in patients treated with 131-iodine for thyroid cancer.
Glanzmann C
Strahlenther Onkol; 1992 Jun; 168(6):337-43. PubMed ID: 1621212
[TBL] [Abstract][Full Text] [Related]
22. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
[TBL] [Abstract][Full Text] [Related]
23. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experience.
Terezakis SA; Lee KS; Ghossein RA; Rivera M; Tuttle RM; Wolden SL; Zelefsky MJ; Wong RJ; Patel SG; Pfister DG; Shaha AR; Lee NY
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):795-801. PubMed ID: 18676097
[TBL] [Abstract][Full Text] [Related]
24. Radioiodine therapy for papillary and follicular thyroid carcinoma.
Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
[TBL] [Abstract][Full Text] [Related]
25. [The survival rate of patients with a differentiated thyroid carcinoma without primary percutaneous irradiation of the neck area].
Saur HB; Lerch H; Schober O
Strahlenther Onkol; 1996 Jun; 172(6):306-11. PubMed ID: 8677502
[TBL] [Abstract][Full Text] [Related]
26. [Experience with a high-dose therapy concept in metastatic differentiated thyroid cancer].
Grünwald F; Ruhlmann J; Ammari B; Knopp R; Hotze A; Biersack HJ
Nuklearmedizin; 1988 Dec; 27(6):266-71. PubMed ID: 3217257
[TBL] [Abstract][Full Text] [Related]
27. The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma.
Leeper RD
J Clin Endocrinol Metab; 1973 Jun; 36(6):1143-52. PubMed ID: 4706203
[No Abstract] [Full Text] [Related]
28. Differentiated thyroid cancer in a Swedish county--long-term results and quality of life.
Malterling RR; Andersson RE; Falkmer S; Falkmer U; Niléhn E; Järhult J
Acta Oncol; 2010 May; 49(4):454-9. PubMed ID: 20092427
[TBL] [Abstract][Full Text] [Related]
29. [Beam radiotherapy in treatment of thyroid carcinoma (author's transl)].
Stucchi F; Tordiglione M
Radiol Med; 1980; 66(7-8):527-35. PubMed ID: 7221069
[TBL] [Abstract][Full Text] [Related]
30. [Therapy of differentiated thyroid carcinomas. Prospective study].
Gemsenjäger E; Staub JJ; Heitz PU
Schweiz Med Wochenschr; 1985 Feb; 115(5):153-9. PubMed ID: 3975583
[TBL] [Abstract][Full Text] [Related]
31. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
[TBL] [Abstract][Full Text] [Related]
32. The role of postoperative external-beam radiotherapy in the management of patients with papillary thyroid cancer invading the trachea.
Keum KC; Suh YG; Koom WS; Cho JH; Shim SJ; Lee CG; Park CS; Chung WY; Kim GE
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):474-80. PubMed ID: 16542796
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment of papillary and follicular thyroid carcinoma.
Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
[TBL] [Abstract][Full Text] [Related]
34. [Teleradiotherapy in the treatment of thyroid neoplasms].
Zorat PL; Calzavara F
Chir Ital; 1994; 46(4):61-5. PubMed ID: 7533668
[TBL] [Abstract][Full Text] [Related]
35. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition.
Chow SM; Yau S; Kwan CK; Poon PC; Law SC
Endocr Relat Cancer; 2006 Dec; 13(4):1159-72. PubMed ID: 17158761
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic results of malignant goiter 1960-1980. Significance of percutaneous radiotherapy in well differentiated carcinomas].
Leisner B; Degelmann G; Dirr W; Kanitz W; Büll U; Langhammer H; Lissner J; Pabst HW
Dtsch Med Wochenschr; 1982 Nov; 107(45):1702-7. PubMed ID: 7140548
[TBL] [Abstract][Full Text] [Related]
37. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
[TBL] [Abstract][Full Text] [Related]
38. Intraoperative radiation therapy, endotracheal hyperthermia and IR-192-brachytherapy in patients with advanced thyroid cancer.
Wolf G; Kohek P; Geyer E; Pakisch B; Langsteger W; Ramschak S; Passath A
Acta Med Austriaca; 1996; 23(1-2):76-9. PubMed ID: 8767520
[TBL] [Abstract][Full Text] [Related]
39. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality.
Chow SM; Law SC; Chan JK; Au SK; Yau S; Lau WH
Cancer; 2003 Jul; 98(1):31-40. PubMed ID: 12833452
[TBL] [Abstract][Full Text] [Related]
40. [Reoperation in differentiated carcinoma of the thyroid gland].
Maffei Faccioli A; Pelizzo MR; Toniato A; Bernante P; Piotto A
Chir Ital; 1994; 46(4):59-60. PubMed ID: 7882446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]